Price Alert

NeuroPace Inc. (NPCE)

NASDAQ: NPCE · Real-Time Price · USD

9.03

-0.29 (-3.11%)

At close: Aug 14, 2025, 3:59 PM

9.00

-0.33%

After-hours: Aug 14, 2025, 07:37 PM EDT

-3.11% (1D)

Bid	8.65
Market Cap	298.73M
Revenue (ttm)	84.31M
Net Income (ttm)	-18.22M
EPS (ttm)	-0.82
PE Ratio (ttm)	-11.01
Forward PE	-14.95
Analyst	Buy

Ask	9
Volume	180,074
Avg. Volume (20D)	362,672
Open	9.32
Previous Close	9.32
Day's Range	8.72 - 9.32
52-Week Range	5.45 - 18.98
Beta	1.90

About NPCE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol NPCE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NPCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

NeuroPace has released their quartely earnings on Aug 12, 2025:

Revenue of $23.52M exceeds estimates by $329.44K, with 22.14% YoY growth.

EPS of -0.26 misses estimates by -0.03, with 0.00% YoY growth.

Next Earnings Release

NeuroPace Inc. is scheduled to release its earnings on Nov 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-28.39%

Neuropace shares are trading lower after the compa... Unlock content with Pro Subscription

3 months ago

+20.46%

Neuropace shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance.

News

3 days ago · seekingalpha.com

NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript

NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Joel D. Becker - CEO, President & Director Patrick F.

3 days ago · zacks.com

NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates

NeuroPace, Inc. (NPCE) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.26 per share a year ago.

1 month ago · businesswire.com

NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)---- $NPCE--NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm.

2 months ago · accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:NPCE). Such investors are a...

2 months ago · accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NA...

2 months ago · accessnewswire.com

Potential Securities Fraud: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE)

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible vio...

2 months ago · accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NA...

2 months ago · accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NA...

2 months ago · accessnewswire.com

Fraud Investigation: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) on Behalf of Shareholders

NEW YORK, NY / ACCESS Newswire / June 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible vio...

2 months ago · accessnewswire.com

NPCE ALERT: Ongoing Investigation Into NeuroPace, Inc. - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible vio...

Load More News